Clinical Trial Opens for Patients with High-Grade Neuroendocrine Cancer
A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center. The new trial will test the novel combination of immunotherapy paired with a tumor-busting virus.
9-Apr-2025 8:50 PM EDT
Add to Favorites